<DOC>
	<DOCNO>NCT00811213</DOCNO>
	<brief_summary>The SensAwake™ modification Fisher Paykel automatically titrate positive airway pressure ( APAP ) device aim sense whether patient awake via respiratory pattern differentiate sleep wake . Upon sense patient awake device able reduce positive airway pressure PAP aim improve patient comfort result consolidated sleep . This study investigate Obstructive Sleep Apnea ( OSA ) automatically Adjusting Positive Airway Pressure ( APAP ) device new technology call SensAwake™ . This require experimental confirmation randomise control trial . Double−blind randomise crossover trial compare WASO standard APAP WASO use APAP modify addition SensAwake™ modification consecutive night participant moderate−to−severe OSA . A total number 45 participant recruit OSA population , age 18−65 . Participants consist male female patient diagnose moderate−severe OSA ( Apnea Hypopnea Index ( AHI ) great equal 15 per hour . Eligible participant , accord protocol approve HREC , provide write informed consent enrol study . Patients enrol sequentially accord randomisation list . Patients randomise APAP APAP addition SensAwake™ modification . The investigator study staff blind treatment participant .</brief_summary>
	<brief_title>SensAwake™ Sleep Quality Trial</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Aged 1865 year moderatetosevere OSA ( Apnea Hypopnea index equal great 15 per hour ) . Epworth Sleepiness Scale ( ESS ) score 015 inclusive ( normal moderately severe daytime sleepiness ) . Fluency write spoken English . Do unstable psychiatric disease . No significant sleep disorder . Participants prescribe fitted PAP device past 2 year . Unstable cardiovascular disease ( untreated resistant hypertension acceptable ) . Inability tolerate CPAP due nasal obstruction claustrophobia determine study investigator . Any known factor disease might interfere treatment compliance , study conduct interpretation result psychiatric disease , history non compliance medical regimen , unwillingness comply study requirement . Participation another clinical trial previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>